Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models.
Συγγραφείς: Amini S; Department of Electrical & Computer Engineering, Division of Systems Engineering, and Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA., Hao B; Department of Electrical & Computer Engineering, Division of Systems Engineering, and Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA., Yang J; Department of Electrical & Computer Engineering, Division of Systems Engineering, and Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA., Karjadi C; Framingham Heart Study, Boston University, Framingham, Massachusetts, USA., Kolachalama VB; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.; Faculty of Computing & Data Sciences, Boston University, Boston, Massachusetts, USA.; Department of Computer Science, Boston University, Boston, Massachusetts, USA., Au R; Framingham Heart Study, Boston University, Framingham, Massachusetts, USA.; Departments of Anatomy & Neurobiology, Neurology, and Epidemiology, Boston University School of Medicine and School of Public Health, Boston, Massachusetts, USA., Paschalidis IC; Department of Electrical & Computer Engineering, Division of Systems Engineering, and Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA.; Faculty of Computing & Data Sciences, Boston University, Boston, Massachusetts, USA.
Πηγή: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Aug; Vol. 20 (8), pp. 5262-5270. Date of Electronic Publication: 2024 Jun 25.
Τύπος έκδοσης: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE
Imprint Name(s): Publication: 2020- : Hoboken, NJ : John Wiley & Sons, Ltd.
Original Publication: Orlando, FL : Elsevier, Inc.
Ιατρικοί όροι (MeSH): Alzheimer Disease*/diagnosis , Cognitive Dysfunction*/diagnosis , Neuropsychological Tests*/statistics & numerical data , Disease Progression* , Speech* , Machine Learning*, Humans ; Female ; Male ; Aged ; Natural Language Processing ; Aged, 80 and over
Περίληψη: Introduction: Identification of individuals with mild cognitive impairment (MCI) who are at risk of developing Alzheimer's disease (AD) is crucial for early intervention and selection of clinical trials.
Methods: We applied natural language processing techniques along with machine learning methods to develop a method for automated prediction of progression to AD within 6 years using speech. The study design was evaluated on the neuropsychological test interviews of n = 166 participants from the Framingham Heart Study, comprising 90 progressive MCI and 76 stable MCI cases.
Results: Our best models, which used features generated from speech data, as well as age, sex, and education level, achieved an accuracy of 78.5% and a sensitivity of 81.1% to predict MCI-to-AD progression within 6 years.
Discussion: The proposed method offers a fully automated procedure, providing an opportunity to develop an inexpensive, broadly accessible, and easy-to-administer screening tool for MCI-to-AD progression prediction, facilitating development of remote assessment.
Highlights: Voice recordings from neuropsychological exams coupled with basic demographics can lead to strong predictive models of progression to dementia from mild cognitive impairment. The study leveraged AI methods for speech recognition and processed the resulting text using language models. The developed AI-powered pipeline can lead to fully automated assessment that could enable remote and cost-effective screening and prognosis for Alzehimer's disease.
(© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)
References: Explor Med. 2020;1:406-417. (PMID: 33665648)
J Clin Exp Neuropsychol. 2011 Feb;33(2):187-99. (PMID: 20711906)
Neural Regen Res. 2023 Jan;18(1):119-120. (PMID: 35799523)
PLoS One. 2017 Mar 6;12(3):e0173372. (PMID: 28264071)
Arch Gen Psychiatry. 2006 Aug;63(8):916-24. (PMID: 16894068)
Neuroimage Clin. 2018 Jan 28;18:167-177. (PMID: 29387532)
Sci Rep. 2019 Feb 19;9(1):2235. (PMID: 30783207)
Alzheimers Dement (Amst). 2015 Apr 30;1(2):206-15. (PMID: 27239505)
Alzheimers Dement. 2024 Aug;20(8):5262-5270. (PMID: 38924662)
Alzheimers Res Ther. 2021 Aug 31;13(1):146. (PMID: 34465384)
BMC Med Inform Decis Mak. 2017 Jul 19;17(1):110. (PMID: 28724366)
J Alzheimers Dis. 2013;34(3):681-9. (PMID: 23263232)
N Engl J Med. 2016 Feb 11;374(6):523-32. (PMID: 26863354)
Front Neurol. 2020 Jun 05;11:496. (PMID: 32582013)
BMC Med Inform Decis Mak. 2018 Dec 19;18(1):137. (PMID: 30567554)
J Alzheimers Dis. 2020;76(3):905-922. (PMID: 32568190)
J Aging Health. 2015 Oct;27(7):1199-222. (PMID: 25804903)
Syst Rev. 2020 Apr 2;9(1):71. (PMID: 32241302)
JAMA. 1997 Oct 22-29;278(16):1349-56. (PMID: 9343467)
J Alzheimers Dis. 2021;84(4):1453-1455. (PMID: 34690142)
J Med Syst. 2018 Apr 13;42(5):97. (PMID: 29654417)
Folia Neuropathol. 2019;57(2):87-105. (PMID: 31556570)
J Neurosci. 2010 Dec 15;30(50):16755-62. (PMID: 21159946)
J Int Neuropsychol Soc. 2016 Oct;22(9):937-943. (PMID: 27029348)
Front Psychol. 2021 Mar 23;12:620251. (PMID: 33833713)
Nat Rev Neurol. 2013 Feb;9(2):106-18. (PMID: 23296339)
Front Psychol. 2017 Mar 06;8:269. (PMID: 28321196)
Alzheimers Dement. 2023 Mar;19(3):946-955. (PMID: 35796399)
Alzheimers Dement. 2023 Jan;19(1):307-317. (PMID: 36209495)
Acta Psychiatr Scand. 2009 Apr;119(4):252-65. (PMID: 19236314)
Elife. 2020 Oct 12;9:. (PMID: 33044170)
J Clin Psychol. 1993 Mar;49(2):225-33. (PMID: 8486805)
J Alzheimers Dis. 2021;83(2):581-589. (PMID: 34334396)
Aging (Albany NY). 2019 Apr 30;11(8):2185-2201. (PMID: 31078129)
Neuroimage. 2013 Jan 15;65:511-21. (PMID: 23036450)
Alzheimers Dement (Amst). 2018 Mar 13;10:260-268. (PMID: 29780871)
Brain Inform. 2022 Sep 3;9(1):20. (PMID: 36056985)
Neuropsychology. 2017 Nov;31(8):846-861. (PMID: 29376667)
Lancet. 2016 Jul 30;388(10043):505-17. (PMID: 26921134)
Front Neurol. 2019 Jul 16;10:756. (PMID: 31379711)
Nat Rev Cardiol. 2019 Nov;16(11):687-698. (PMID: 31065045)
Grant Information: R01 AG016495 United States AG NIA NIH HHS; R01 GM135930 United States GM NIGMS NIH HHS; RF1 AG062109 United States AG NIA NIH HHS; DMS-1664644 NSF; AG16495 United States AG NIA NIH HHS; AG072654 United States AG NIA NIH HHS; AG068753 United States AG NIA NIH HHS; R01 AG072654 United States AG NIA NIH HHS; AG008122 United States AG NIA NIH HHS; IIS-1914792 NSF; U19 AG068753 United States AG NIA NIH HHS; R01 AG062109 United States AG NIA NIH HHS; CCF-2200052 NSF; UL54 TR00413 United States GF NIH HHS; RF1 AG072654 United States AG NIA NIH HHS; R01 GM135930 United States GF NIH HHS; R01 AG008122 United States AG NIA NIH HHS; N01-HC-25195 United States HL NHLBI NIH HHS; R56 AG062109 United States AG NIA NIH HHS; AG062109 United States AG NIA NIH HHS
Contributed Indexing: Keywords: Alzheimer's disease prognosis; Framingham Heart Study; natural language processing; neuropsychological test
Entry Date(s): Date Created: 20240626 Date Completed: 20240828 Latest Revision: 20260314
Update Code: 20260314
PubMed Central ID: PMC11350035
DOI: 10.1002/alz.13886
PMID: 38924662
Βάση Δεδομένων: MEDLINE